Metabolic syndrome and cardiometabolic risk in PCOS.
The cardiovascular risk associated with the polycystic ovary syndrome (PCOS) has recently attracted much interest. Women with PCOS are more likely to fulfill the diagnosis of the metabolic syndrome, a cluster of related cardiometabolic factors known to predict long-term risk of cardiovascular disease and type 2 diabetes. We review the literature pertaining to the link between the metabolic syndrome, cardiovascular disease, and PCOS. We focus on the influence of obesity and hyperandrogenemia, and on strategies for identifying cardiovascular risk in PCOS.
Cussons
Andrea J
AJ
School of Medicine and Pharmacology, University of Western Australia, Royal Perth Hospital, GPO Box X2213, Perth, Western Australia.
Stuckey
Bronwyn G A
BG
Watts
Gerald F
GF
D000728:Androgens / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000150:complications* / Q000378:metabolism* / Q000473:pathology; D018450:Disease Progression; D005260:Female; D006801:Humans; D024821:Metabolic Syndrome / Q000150:complications* / Q000378:metabolism* / Q000473:pathology; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000378:metabolism* / Q000473:pathology; D012307:Risk Factors
D000728:Androgens